Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

NCT03159143 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Transitional Cell Cancer of the Urothelial Tract

Interventions

DRUG: Docetaxel
DRUG: Oxaliplatin

Sponsor

Leonard Appleman

Collaborators

[object Object]